Hostname: page-component-cd9895bd7-q99xh Total loading time: 0 Render date: 2024-12-27T12:34:36.133Z Has data issue: false hasContentIssue false

Nasal sarcoidosis: a cause for a medical rhinoplasty?

Published online by Cambridge University Press:  12 July 2012

J van Griethuysen*
Affiliation:
Otolaryngology, Head and Neck Surgery Department, Charing Cross Hospital, Imperial College London, UK
R Kuchai
Affiliation:
Otolaryngology, Head and Neck Surgery Department, Charing Cross Hospital, Imperial College London, UK
A S Taghi
Affiliation:
Otolaryngology, Head and Neck Surgery Department, Charing Cross Hospital, Imperial College London, UK
H A Saleh
Affiliation:
Otolaryngology, Head and Neck Surgery Department, Charing Cross Hospital, Imperial College London, UK
*
Address for correspondence: Dr Jennifer van Griethuysen, Otolaryngology, Head and Neck Surgery Department, Charing Cross Hospital, Fulham Palace Road, London W6 8RF, UK E-mail: jmv04@imperial.ac.uk

Abstract

Objective:

We report the use of triamcinolone injections to correct severe nasal deformity due to sarcoidosis, as an alternative to formal surgical rhinoplasty.

Case report:

A 30-year-old woman with a long-standing history of sarcoidosis presented to a tertiary referral rhinology clinic complaining of breathing difficulty and nasal deformity. Flexible nasoendoscopy revealed red nasal plaques typical of nasal sarcoidosis, together with significant widening of the nasal bridge. Triamcinolone, a long-acting corticosteroid, was injected both intralesionally and subcutaneously over the nasal dorsum, at zero, three and eight months, resulting in long-lasting improvement of the nasal shape.

Conclusion:

Sarcoidosis is a non-caseating, granulomatous, epithelioid inflammation. Otorhinolaryngological manifestations occur in approximately 10 per cent of patients; however, there is little published experience of nasal reconstruction in such patients. We describe a quick, simple and relatively cost-effective technique, with little or no co-morbidity, with which to improve the aesthetic and symptomatic outcomes of nasal sarcoidosis.

Type
Clinical Records
Copyright
Copyright © JLO (1984) Limited 2012

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

Presented as a poster to the British Rhinological Society Meeting, 13 May 2011, Edinburgh, Scotland, UK

References

1Newman, LS, Rose, CS, Maier, LA. Sarcoidosis. N Engl J Med 1997;336:1224–34CrossRefGoogle ScholarPubMed
2Wilson, NJ, King, CM. Cutaneous sarcoidosis. Postgrad Med J 1998;74:649–52CrossRefGoogle ScholarPubMed
3Shah, UK, White, JA, Gooey, JE, Hybels, RL. Otolaryngologic manifestation of sarcoidosis: presentation and diagnosis. Laryngoscope 1997;107:6775CrossRefGoogle ScholarPubMed
4Zeitlin, JF, Tami, TA, Burgman, R, Winget, D. Nasal and sinus manifestation of sarcoidosis. Am J Rhinol 2000;14:157–61CrossRefGoogle ScholarPubMed
5English, JC, Patel, PJ, Greer, KE. Sarcoidosis. J Am Acad Dermatol 2001;44:725–43CrossRefGoogle Scholar
6Preminger, BA, Hiltzik, DH, Segal, J, Morrison, NG. An operative approach to the treatment of refractory cutaneous nasal sarcoid: a case report and review of the literature. Ann Plast Surg 2009;63:685–7CrossRefGoogle Scholar
7Baughman, RP, Lower, EE. Infliximab for refractory sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2001;18:70–4, 310Google ScholarPubMed
8Carlesimo, M, Giustini, S, Rossi, A, Bonaccorsi, P, Calvieri, S. Treatment of cutaneous and pulmonary sarcoidosis with thalidomide. J Am Acad Dermatol 1995;32:866–9CrossRefGoogle ScholarPubMed
9Young, HS, Chalmers, RJ, Griffiths, CE, August, PJ. CO2 laser vaporization for disfiguring lupus pernio. J Cosmet Laser Ther 2002;4:8790CrossRefGoogle ScholarPubMed
10O'Donoghue, NB, Barlow, RJ. Laser remodeling of nodular nasal lupus pernio. Clin Exp Dermatol 2006;31:27–9CrossRefGoogle ScholarPubMed